SAN DIEGO, March 13 /PRNewswire-FirstCall/ — Nanogen, Inc. (Nasdaq: NGEN), developer of advanced diagnostic products, announced today that it was issued U.S. Patent No. 6,989,086, “Channel-less Separation of Bioparticles on a Bioelectronic Chip by Dielectrophoresis” by the U.S. Patent and Trademark Office. The ‘086 patent relates to a method of separating biomolecules or cell particles on a chip using electronic current to preferentially attract specific molecules or cellular components.

SAN DIEGO, March 13 /PRNewswire-FirstCall/ — Nanogen, Inc. (Nasdaq: NGEN), developer of advanced diagnostic products, announced today that it was issued U.S. Patent No. 6,989,086, “Channel-less Separation of Bioparticles on a Bioelectronic Chip by Dielectrophoresis” by the U.S. Patent and Trademark Office. The ‘086 patent relates to a method of separating biomolecules or cell particles on a chip using electronic current to preferentially attract specific molecules or cellular components.

PerkinElmer Inc. (NYSE: PKI), a global leader in Health Sciences and Photonics, today announced new application-based laboratory solutions and product enhancements for the environmental, pharmaceutical, materials and academic research market segments at PITTCON(R) 2006, March 13-15, booth # 2669.

KREATECH Biotechnology is pleased to announce the release of the latest in a line of labeling kits for small RNA/miRNA analysis applications and the first complete kit for miRNA isolation and labeling, the “miRacULS miRNA Isolation and Labeling Kit”.

WAUKESHA, WISC, - GE Healthcare announced today that the company has signed a six-year research agreement with St. Joseph’s Hospital and Medical Center to establish a landmark alliance in medical research. The agreement is expected to advance personalized healthcare by accelerating joint research efforts and quickly transitioning those discoveries into the clinical environment.

BioSystems International and Northeastern University announced today that they have signed a licence agreement for the University’s monoclonal antibody based biomarker discovery and development platform.

Blacksburg, Va., March 9, 2006 — Researchers at the Virginia Bioinformatics Institute at Virginia Tech have launched a publicly-available microbial database to host a range of microbial genome sequences.

BOSTON—(BUSINESS WIRE)—March 9, 2006—PerkinElmer, Inc. (NYSE: PKI), a global technology leader in Health Sciences and Photonics, today announced the acquisition of Agilix Corporation’s proprietary proteomics technology.

Princeton, NJ, Mar. 9, 2006 - Orchid Cellmark Inc. (Nasdaq: ORCH), a leading worldwide provider of identity DNA testing services, today announced that its Board of Directors has appointed Thomas A. Bologna as the company’s new president and chief executive officer. Mr. Bologna fills these positions that had been held by Dr. Paul Kelly, who has left the company. Mr. Bologna will also serve as a director of Orchid Cellmark.

Woburn, MA, March 8, 2006 - BioTrove, Inc. announced today that the company has successfully completed its latest fundraising by closing an additional $7 million in an oversubscribed round of venture capital funding. This brings the total amount raised since July 2005 to $15 million. Participating investors include Catalyst Health and Technology Partners, Echelon Ventures, Fletcher Spaght, and CB Health Ventures. The proceeds of this round will accelerate the commercialization of BioTrove’s OpenArray™ genomics and RapidFire™ pharmaceutical screening products.

Edmonton, Alberta, March 8, 2006 - Micralyne Inc., a world-leading manufacturer of MEMS (Micro-Electro-Mechanical Systems)-based industrial components, reports success penetrating the emerging MEMS market in Asia. Building on its position as one of the largest independent MEMS foundries in North America, Micralyne has successfully extended its reach to Asia by serving market leading companies in Japan and China.

SANTA CLARA, Calif.—(BUSINESS WIRE)—March 8, 2006—Affymetrix Inc. (Nasdaq:AFFX) announced today that Korea’s National Institute of Health (NIH) and Center for Disease Control and Prevention will use the Affymetrix GeneChip(R) Human Mapping 500K Array Set for a series of groundbreaking genome-wide association studies in critical disease areas, including diabetes, hypertension, asthma and metabolic syndrome.

Fullerton, California, March 2006 – Beckman Coulter introduces IOTest® CD136 (RON)-PE conjugated monoclonal antibody for the identification of a receptor protein kinase potentially involved in tumour development and growth. The CD136 antigen is the product of the recepteur d’origine nantais (RON) gene. It is mainly expressed on cells of epithelial origin. The RON receptor belongs to a group of kinases that play important regulatory roles in normal tissue and can also be involved in cellular disorganization and alteration when overexpressed or mutated.

Proteome Systems Ltd (ASX:PXL) today announced the signing of an agreement with the New York based biotechnology company, Egenix Inc to co-develop a semen-based diagnostic kit for prostate cancer based on the known proprietary Human Carcinoma Antigen (HCA)

KREATECH Biotechnology is pleased to announce the expansion of their line of ULS aRNA labeling kits with biotin ULS for Affymetrix® GeneChip® users and gene expression applications. The new formats are aimed at providing more specific kit formulations to Affymetrix® platform customers and other single color users by offering more choice than before.